Glooko Highlights Inpatient Insulin Management Solution at Hospital Medicine Conference

According to a recent LinkedIn post from Glooko, the company’s team is participating in the 2026 Society of Hospital Medicine Converge Conference, where it is showcasing the EndoTool Glucose Management System. The post indicates that EndoTool, developed by Monarch Medical Technologies, a Glooko company, is positioned as a tool for redefining inpatient insulin management.

The LinkedIn post also suggests that Glooko is emphasizing how this solution may assist hospitals with mandatory Centers for Medicare & Medicaid Services (CMS) glycemic safety reporting requirements. For investors, this focus on inpatient glycemic management and regulatory reporting could signal Glooko’s effort to deepen its presence in the hospital market and align its offerings with compliance-driven demand, potentially supporting longer-term adoption and recurring revenue opportunities.